The stock of SELLAS Life Sciences Group Inc (SLS) has gone up by 0.65% for the week, with a -4.91% drop in the past month and a 43.52% rise in the past quarter. The volatility ratio for the week is 5.85%, and the volatility levels for the past 30 days are 6.00% for SLS. The simple moving average for the past 20 days is -7.63% for SLS’s stock, with a 22.82% simple moving average for the past 200 days.
Is It Worth Investing in SELLAS Life Sciences Group Inc (NASDAQ: SLS) Right Now?
Company’s 36-month beta value is 2.27.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SLS is 97.67M, and currently, short sellers hold a 12.51% ratio of that floaft. The average trading volume of SLS on June 17, 2025 was 2.03M shares.
SLS) stock’s latest price update
The stock price of SELLAS Life Sciences Group Inc (NASDAQ: SLS) has plunged by -3.73 when compared to previous closing price of 1.61, but the company has seen a 0.65% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-05 that New appointments of Drs. Philip C. Amrein and Alex Kentsis Validate Lead Galinpepimut-S and SLS009 Programs as Company Approaches Key Inflection Points This Year New appointments of Drs. Philip C. Amrein and Alex Kentsis Validate Lead Galinpepimut-S and SLS009 Programs as Company Approaches Key Inflection Points This Year
Analysts’ Opinion of SLS
Many brokerage firms have already submitted their reports for SLS stocks, with Cantor Fitzgerald repeating the rating for SLS by listing it as a “Overweight.” The predicted price for SLS in the upcoming period, according to Cantor Fitzgerald is $18 based on the research report published on July 21, 2021 of the previous year 2021.
H.C. Wainwright gave a rating of “Buy” to SLS, setting the target price at $11 in the report published on April 02nd of the previous year.
SLS Trading at 1.68% from the 50-Day Moving Average
After a stumble in the market that brought SLS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -26.89% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SLS starting from VAN NOSTRAND ROBERT L, who purchase 10,000 shares at the price of $1.48 back on Jun 12 ’25. After this action, VAN NOSTRAND ROBERT L now owns 20,400 shares of SELLAS Life Sciences Group Inc, valued at $14,800 using the latest closing price.
Wasman Jane, the Director of SELLAS Life Sciences Group Inc, purchase 20,000 shares at $1.69 during a trade that took place back on May 30 ’25, which means that Wasman Jane is holding 30,400 shares at $33,800 based on the most recent closing price.
Stock Fundamentals for SLS
The total capital return value is set at -1.0. Equity return is now at value -144.90, with -91.36 for asset returns.
Based on SELLAS Life Sciences Group Inc (SLS), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -38.75.
Currently, EBITDA for the company is -30.88 million with net debt to EBITDA at 0.99. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.64.
Conclusion
In a nutshell, SELLAS Life Sciences Group Inc (SLS) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
